The factsheet has been successfully sent.
Please check your inbox.
Please fill in the form to receive the factsheet directly into your inbox
Submit
Cancel

0
You have items in your inquiry list.
Inquire now?

28 April 2021 [Press release]

Product Launch GenoQuest GBS qPCR Assay

The CE-IVD marked GenoQuestTM GBS qPCR Assay is designed for the qualitative identification of Group B Streptococcus, a common commensal gram-positive bacteria colonized within the gastrointestinal and urogenital tracts of ~30% of healthy individuals. Maternal GBS transmission to newborns remains a global public health concern as it is the causing agent of early-onset neonatal GBS infection which is often life-threatening. The universal screening of maternal GBS colonization continues to be the cornerstone of GBS disease prevention.
 
Click here to read more about the GBS qPCR Assay.

About DiagCor

Headquartered in Hong Kong, DiagCor has been dedicated solely to molecular diagnostics (MDx) since 2006. The global leader in flow-through hybridization technology, the company offers a range of products, solutions and services related to RNA and DNA analysis. As well as providing MDx laboratory services to Asia Pacific practitioners, Diagcor develops and manufactures MDx products and solutions, and offers MDx medical translation services and MDx consulting.



Press Contact

DiagCor Life Science

sales@diagcorlifescience.com